Human prothrombin complex (CSL Behring)

N/A

Report date: 2024/07/15 20:00:35

Base Information

Drug NameHuman prothrombin complex (CSL Behring)
Drug Alias Name4FPCC4-factor PCCConfidexBeriplexKcentra +[6] 
ClassificationBiologics > Blood components
Mechanisms of ActionCoagulation factor VII modulatorsCoagulation factor X modulatorsCoagulation factor IX modulators +[4] 
TargetsCoagulation factor VIIProthrombinCoagulation factor IX +[4] 
Therapy Area/IndicationsWounds and InjuriesHemorrhageVitamin K Deficiency Bleeding +[8] 
Global Approved IndicationsVitamin K Deficiency Bleeding
Approved Indications in ChinaN/A
Original Approved Country/TerritoryJapan
Original Approved DateN/A
Country/TerritoryBulgariaUnited StatesUkraine +[17] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesCsl Behring Llc
China Registration ClassN/A

Develop Information

Active CompaniesCsl Behring KkOregon Health And Science UniversityCsl Behring Llc
Inactive CompaniesCsl BehringUniversity Of Maryland, Baltimore
Active IndicationsWounds and InjuriesHemorrhageVitamin K Deficiency Bleeding
Inactive IndicationsCoagulation Protein DisordersBlood Coagulation DisordersHeart Failure +[5] 

Other Information

ATC CodeB02BD01
Related LinksWikipedia